🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Terminated
Location
University of Chicago Cancer Research Center
Start Date
1999-12
Trial ID
NCT00004239
Treatments Being Tested
This is a 3-part study to assess the safety of adding capivasertib to a sta...
Status
Recruiting
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2026-03-17
Trial ID
NCT07294677
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
1999-09
Trial ID
NCT00003837
Treatments Being Tested
This international, multicentre, single arm, phase IV study will assess the...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00866671
Treatments Being Tested
This phase II trial tests the safety and effectiveness of giving chemothera...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-08-09
Trial ID
NCT06210750
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of venetoclax ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-04-03
Trial ID
NCT03808610
The purpose of this study is to evaluate the efficacy of nelarabine-based c...
Status
Unknown
Location
Hematology
Start Date
2015-12
Trial ID
NCT02619630
Treatments Being Tested
The outcome of patients with relapsed or refractory adult T-acute lymphobla...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2016-12-02
Trial ID
NCT02763384
Treatments Being Tested
In Japan, patients with relapsed or refractory T-ALL/T-LBL represent an ext...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-08-30
Trial ID
NCT00406757